Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has provided an announcement.
CANbridge Pharmaceuticals Inc. has established a Nomination and Corporate Governance Committee, as resolved by its Board of Directors on June 21, 2021. This move is part of the company’s efforts to enhance its corporate governance structure, which could potentially strengthen its industry positioning and provide better oversight for stakeholders.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and commercialization of therapies for rare diseases and targeted cancers, with a market focus on innovative healthcare solutions.
Average Trading Volume: 5,299,196
Technical Sentiment Signal: Sell
Current Market Cap: HK$119M
Find detailed analytics on 1228 stock on TipRanks’ Stock Analysis page.